This article was orignally published Aug. 25.
Ambry Genetics has acquired an Illumina HiSeq 2000 sequencer for its service business, along with an Illumina BeadXpress genotyping system.
The HiSeq will allow the Aliso Viejo, Calif.-based firm "to run large projects for its customers while saving costs and providing the fastest turnaround times for sequencing," according to a company statement. Ambry has provided sequencing services on the Illumina Genome Analyzer since 2007.
Ambry, which has a CAP-accredited and CLIA-certified clinical laboratory, offers both genomic services and genetic diagnostic and carrier testing.
An Illumina-certified service provider, it currently provides a variety of sequencing services on the GAIIx, including whole-genome sequencing, exome sequencing, and RNA sequencing. For targeted sequencing, the company uses the Agilent SureSelect, RainDance, and Roche NimbleGen enrichment methods.
This spring, Ambry said it was working on a sequencing-based genetic carrier screening test to assay known mutations involved in more than 90 genetic diseases (IS 5/18/2010).